These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 12446181)
1. Effects of carbohydrate polymers applicable in saliva substitutes on the anti-Candida activity of a histatin-derived peptide. Ruissen AL; Groenink J; Lommerse CH; Van 't Hof W; Veerman EC; Nieuw Amerongen AV Arch Oral Biol; 2002 Nov; 47(11):749-56. PubMed ID: 12446181 [TBL] [Abstract][Full Text] [Related]
2. Influence of polymers for use in saliva substitutes on de- and remineralization of enamel in vitro. van der Reijden WA; Buijs MJ; Damen JJ; Veerman EC; ten Cate JM; Nieuw Amerongen AV Caries Res; 1997; 31(3):216-23. PubMed ID: 9165194 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the use of xanthan as vehicle for cationic antifungal peptides. Ruissen AL; van der Reijden WA; van't Hof W; Veerman EC; Nieuw Amerongen AV J Control Release; 1999 Jun; 60(1):49-56. PubMed ID: 10370170 [TBL] [Abstract][Full Text] [Related]
4. Candida albicans mutants deficient in respiration are resistant to the small cationic salivary antimicrobial peptide histatin 5. Gyurko C; Lendenmann U; Troxler RF; Oppenheim FG Antimicrob Agents Chemother; 2000 Feb; 44(2):348-54. PubMed ID: 10639361 [TBL] [Abstract][Full Text] [Related]
6. Characterization of histatin 5 with respect to amphipathicity, hydrophobicity, and effects on cell and mitochondrial membrane integrity excludes a candidacidal mechanism of pore formation. Helmerhorst EJ; van't Hof W; Breeuwer P; Veerman EC; Abee T; Troxler RF; Amerongen AV; Oppenheim FG J Biol Chem; 2001 Feb; 276(8):5643-9. PubMed ID: 11099499 [TBL] [Abstract][Full Text] [Related]
7. Effects of histatin 5 modifications on antifungal activity and kinetics of proteolysis. Ikonomova SP; Moghaddam-Taaheri P; Wang Y; Doolin MT; Stroka KM; Hube B; Karlsson AJ Protein Sci; 2020 Feb; 29(2):480-493. PubMed ID: 31675138 [TBL] [Abstract][Full Text] [Related]
8. Killing of Candida albicans by histatin 5: cellular uptake and energy requirement. Gyurko C; Lendenmann U; Helmerhorst EJ; Troxler RF; Oppenheim FG Antonie Van Leeuwenhoek; 2001 Sep; 79(3-4):297-309. PubMed ID: 11816973 [TBL] [Abstract][Full Text] [Related]
9. Anticandida activity is retained in P-113, a 12-amino-acid fragment of histatin 5. Rothstein DM; Spacciapoli P; Tran LT; Xu T; Roberts FD; Dalla Serra M; Buxton DK; Oppenheim FG; Friden P Antimicrob Agents Chemother; 2001 May; 45(5):1367-73. PubMed ID: 11302797 [TBL] [Abstract][Full Text] [Related]
10. Effects of histatin 5 and derived peptides on Candida albicans. Ruissen AL; Groenink J; Helmerhorst EJ; Walgreen-Weterings E; Van't Hof W; Veerman EC; Nieuw Amerongen AV Biochem J; 2001 Jun; 356(Pt 2):361-8. PubMed ID: 11368762 [TBL] [Abstract][Full Text] [Related]
11. In vitro synergic antifungal effect of MUC7 12-mer with histatin-5 12-mer or miconazole. Wei GX; Bobek LA J Antimicrob Chemother; 2004 May; 53(5):750-8. PubMed ID: 15073161 [TBL] [Abstract][Full Text] [Related]
12. Engineering improved variants of the antifungal peptide histatin 5 with reduced susceptibility to Candida albicans secreted aspartic proteases and enhanced antimicrobial potency. Ikonomova SP; Moghaddam-Taaheri P; Jabra-Rizk MA; Wang Y; Karlsson AJ FEBS J; 2018 Jan; 285(1):146-159. PubMed ID: 29143452 [TBL] [Abstract][Full Text] [Related]
13. The Interactions between the Antimicrobial Peptide P-113 and Living Cheng KT; Wu CL; Yip BS; Chih YH; Peng KL; Hsu SY; Yu HY; Cheng JW Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32290246 [TBL] [Abstract][Full Text] [Related]